Patient Conditions/Disease States

On Jan. 11, CMS released a proposed coverage decision that would cover the costs of monoclonal antibody treatments for Alzheimer's Disease patients only if they are enrolled in clinical trials.

Sponsored webinar that discussed Parkinson’s Disease psychosis and the many considerations regarding antipsychotic treatment in these patients from the payer perspective.

AMCP Foundation and CVS Health proudly announced the recipients of AMCP Foundation Best Poster Awards at AMCP 2021 Virtual.

Sponsored webinar that provided insights into the "hidden" burden of Systemic Lupus Erythematosus (SLE): a multisystemic autoimmune disease.

Sponsored webinar that discussed topics such as, the RNAi overview, the disease burden of PH1, PH2 and PH3, and an RNAi technology as a potential treatment approach for this rare condition.

Partnership Forum: This forum identified key actions that can support access to and the appropriate management of treatments for rare diseases within the U.S. health care system.

Sponsored webinar that provided an overview of the ATTR amyloidosis disease subtypes, pathophysiology of disease, and the varying clinical presentations, including nonspecific symptoms that should raise suspicion of and aid in diagnosis of the disease.

More than 30 experts representing health plans, integrated delivery systems, health economists, providers, academicians, pharmaceutical manufacturers, and other professionals gathered for AMCP’s Partnership Forum to address the challenges in managing and providing timely access to rare and orphan disease therapies.

Sponsored webinar that educated payers on the important features of axial spondyloarthritis (axSpA) to help with early detection.